Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 1.64
NYSE:WAT's Cash-to-Debt is ranked higher than
50% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. NYSE:WAT: 1.64 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:WAT' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 1.03 Max: 336.71
Current: 1.64
0
336.71
Equity-to-Asset 0.50
NYSE:WAT's Equity-to-Asset is ranked lower than
65% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. NYSE:WAT: 0.50 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:WAT' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.05  Med: 0.45 Max: 0.7
Current: 0.5
-0.05
0.7
Debt-to-Equity 0.76
NYSE:WAT's Debt-to-Equity is ranked lower than
74% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.35 vs. NYSE:WAT: 0.76 )
Ranked among companies with meaningful Debt-to-Equity only.
NYSE:WAT' s Debt-to-Equity Range Over the Past 10 Years
Min: -27.63  Med: 0.81 Max: 5.91
Current: 0.76
-27.63
5.91
Debt-to-EBITDA 2.51
NYSE:WAT's Debt-to-EBITDA is ranked lower than
59% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. NYSE:WAT: 2.51 )
Ranked among companies with meaningful Debt-to-EBITDA only.
NYSE:WAT' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.13  Med: 2.03 Max: 2.51
Current: 2.51
1.13
2.51
Interest Coverage 12.50
NYSE:WAT's Interest Coverage is ranked lower than
69% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 44.21 vs. NYSE:WAT: 12.50 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:WAT' s Interest Coverage Range Over the Past 10 Years
Min: 6.17  Med: 16.44 Max: 35.92
Current: 12.5
6.17
35.92
Piotroski F-Score: 6
Altman Z-Score: 6.88
Beneish M-Score: -2.59
WACC vs ROIC
8.83%
42.51%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 28.61
NYSE:WAT's Operating Margin % is ranked higher than
95% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.72 vs. NYSE:WAT: 28.61 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:WAT' s Operating Margin % Range Over the Past 10 Years
Min: 23.68  Med: 27.28 Max: 28.81
Current: 28.61
23.68
28.81
Net Margin % 24.26
NYSE:WAT's Net Margin % is ranked higher than
93% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. NYSE:WAT: 24.26 )
Ranked among companies with meaningful Net Margin % only.
NYSE:WAT' s Net Margin % Range Over the Past 10 Years
Min: 18.2  Med: 23.1 Max: 25.03
Current: 24.26
18.2
25.03
ROE % 23.08
NYSE:WAT's ROE % is ranked higher than
89% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.68 vs. NYSE:WAT: 23.08 )
Ranked among companies with meaningful ROE % only.
NYSE:WAT' s ROE % Range Over the Past 10 Years
Min: 23.08  Med: 36 Max: 56.53
Current: 23.08
23.08
56.53
ROA % 11.42
NYSE:WAT's ROA % is ranked higher than
83% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.36 vs. NYSE:WAT: 11.42 )
Ranked among companies with meaningful ROA % only.
NYSE:WAT' s ROA % Range Over the Past 10 Years
Min: 11.42  Med: 15.5 Max: 18.41
Current: 11.42
11.42
18.41
ROC (Joel Greenblatt) % 88.46
NYSE:WAT's ROC (Joel Greenblatt) % is ranked higher than
92% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.63 vs. NYSE:WAT: 88.46 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:WAT' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 72.34  Med: 85.19 Max: 96.98
Current: 88.46
72.34
96.98
3-Year Revenue Growth Rate 6.60
NYSE:WAT's 3-Year Revenue Growth Rate is ranked higher than
59% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.90 vs. NYSE:WAT: 6.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:WAT' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 5.2  Med: 8.9 Max: 19.5
Current: 6.6
5.2
19.5
3-Year EBITDA Growth Rate 9.50
NYSE:WAT's 3-Year EBITDA Growth Rate is ranked higher than
60% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. NYSE:WAT: 9.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:WAT' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 2.4  Med: 11 Max: 69.2
Current: 9.5
2.4
69.2
3-Year EPS without NRI Growth Rate 7.20
NYSE:WAT's 3-Year EPS without NRI Growth Rate is ranked higher than
54% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. NYSE:WAT: 7.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:WAT' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 2.6  Med: 14.6 Max: 79.9
Current: 7.2
2.6
79.9
GuruFocus has detected 3 Warning Signs with Waters Corp NYSE:WAT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:WAT's 30-Y Financials

Financials (Next Earnings Date: 2017-10-24)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

WAT Guru Trades in Q3 2016

Jim Simons 20,200 sh (New)
Paul Tudor Jones 3,900 sh (+39.29%)
Ruane Cunniff 1,777,909 sh (+0.45%)
Chuck Royce 5,047 sh (unchged)
Pioneer Investments 8,690 sh (unchged)
Louis Moore Bacon Sold Out
Ray Dalio Sold Out
PRIMECAP Management 488,487 sh (-22.30%)
Joel Greenblatt 41,642 sh (-60.55%)
» More
Q4 2016

WAT Guru Trades in Q4 2016

Jim Simons 195,300 sh (+866.83%)
Joel Greenblatt 56,708 sh (+36.18%)
Paul Tudor Jones 4,190 sh (+7.44%)
Pioneer Investments 8,690 sh (unchged)
Chuck Royce Sold Out
Ruane Cunniff 1,718,469 sh (-3.34%)
PRIMECAP Management 471,657 sh (-3.45%)
» More
Q1 2017

WAT Guru Trades in Q1 2017

Pioneer Investments Sold Out
Ruane Cunniff 1,669,196 sh (-2.87%)
PRIMECAP Management 436,137 sh (-7.53%)
Jim Simons 167,400 sh (-14.29%)
Joel Greenblatt 40,730 sh (-28.18%)
Paul Tudor Jones 1,700 sh (-59.43%)
» More
Q2 2017

WAT Guru Trades in Q2 2017

Lee Ainslie 21,580 sh (New)
Pioneer Investments 37,476 sh (New)
Jim Simons 526,400 sh (+214.46%)
Ruane Cunniff 1,788,992 sh (+7.18%)
Paul Tudor Jones Sold Out
Joel Greenblatt 38,831 sh (-4.66%)
PRIMECAP Management 365,007 sh (-16.31%)
» More
» Details

Insider Trades

Latest Guru Trades with WAT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ruane Cunniff 2017-06-30 Add 7.18%0.2%$154.83 - $186.33 $ 188.149%1,788,992
Joel Greenblatt 2017-06-30 Reduce -4.66%$154.83 - $186.33 $ 188.149%38,831
Ruane Cunniff 2017-03-31 Reduce -2.87%0.06%$135.49 - $158.31 $ 188.1426%1,669,196
Joel Greenblatt 2017-03-31 Reduce -28.18%0.03%$135.49 - $158.31 $ 188.1426%40,730
Ruane Cunniff 2016-12-31 Reduce -3.34%0.09%$133.71 - $159.05 $ 188.1432%1,718,469
Joel Greenblatt 2016-12-31 Add 36.18%0.03%$133.71 - $159.05 $ 188.1432%56,708
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:TSE:4543, NAS:XRAY, NYSE:MTD, TSE:7733, NYSE:COO, OCSE:COLO B, NYSE:RMD, NAS:HOLX, XSWX:STMN, NYSE:STE, NYSE:WST, NYSE:BCR, SZSE:002294, NYSE:HRC, OSTO:GETI B, NAS:ICUI, NYSE:CMD, MIL:AMP, NAS:PODD, TSE:7747 » details
Traded in other countries:WAZ.Germany,
Headquarter Location:USA
Waters Corp is an analytical instrument manufacturer. It designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography & mass spectrometry instrument systems & support products.

Waters provides analytical instruments for pharmaceutical, biochemical, and industrial customers. Roughly half of sales are attributable to instruments, which include liquid chromatography and mass spectrometry platforms, as well as thermal analysis tools. Consumables and services account for the remainder of Waters' sales.

Ratios

vs
industry
vs
history
PE Ratio 28.42
WAT's PE Ratio is ranked higher than
56% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.08 vs. WAT: 28.42 )
Ranked among companies with meaningful PE Ratio only.
WAT' s PE Ratio Range Over the Past 10 Years
Min: 9.64  Med: 20.9 Max: 32.25
Current: 28.42
9.64
32.25
Forward PE Ratio 23.81
WAT's Forward PE Ratio is ranked higher than
60% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.51 vs. WAT: 23.81 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 28.42
WAT's PE Ratio without NRI is ranked higher than
57% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. WAT: 28.42 )
Ranked among companies with meaningful PE Ratio without NRI only.
WAT' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.64  Med: 20.9 Max: 32.25
Current: 28.42
9.64
32.25
Price-to-Owner-Earnings 28.05
WAT's Price-to-Owner-Earnings is ranked higher than
60% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.51 vs. WAT: 28.05 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
WAT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.12  Med: 22.95 Max: 34.46
Current: 28.05
10.12
34.46
PB Ratio 5.98
WAT's PB Ratio is ranked lower than
73% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. WAT: 5.98 )
Ranked among companies with meaningful PB Ratio only.
WAT' s PB Ratio Range Over the Past 10 Years
Min: 4.38  Med: 5.74 Max: 17.2
Current: 5.98
4.38
17.2
PS Ratio 6.89
WAT's PS Ratio is ranked lower than
74% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.36 vs. WAT: 6.89 )
Ranked among companies with meaningful PS Ratio only.
WAT' s PS Ratio Range Over the Past 10 Years
Min: 2.05  Med: 4.57 Max: 6.89
Current: 6.89
2.05
6.89
Price-to-Free-Cash-Flow 26.51
WAT's Price-to-Free-Cash-Flow is ranked higher than
61% of the 72 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.99 vs. WAT: 26.51 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
WAT' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.66  Med: 22.47 Max: 30.04
Current: 26.51
9.66
30.04
Price-to-Operating-Cash-Flow 23.08
WAT's Price-to-Operating-Cash-Flow is ranked lower than
54% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.95 vs. WAT: 23.08 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
WAT' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.82  Med: 18.12 Max: 24.68
Current: 23.08
7.82
24.68
EV-to-EBIT 20.91
WAT's EV-to-EBIT is ranked higher than
61% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.17 vs. WAT: 20.91 )
Ranked among companies with meaningful EV-to-EBIT only.
WAT' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.1  Med: 16.4 Max: 23.6
Current: 20.91
8.1
23.6
EV-to-EBITDA 18.14
WAT's EV-to-EBITDA is ranked higher than
56% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.83 vs. WAT: 18.14 )
Ranked among companies with meaningful EV-to-EBITDA only.
WAT' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7  Med: 14.2 Max: 20.6
Current: 18.14
7
20.6
EV-to-Revenue 6.24
WAT's EV-to-Revenue is ranked lower than
68% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. WAT: 6.24 )
Ranked among companies with meaningful EV-to-Revenue only.
WAT' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.1  Med: 4.4 Max: 6.3
Current: 6.24
2.1
6.3
PEG Ratio 4.06
WAT's PEG Ratio is ranked lower than
62% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. WAT: 4.06 )
Ranked among companies with meaningful PEG Ratio only.
WAT' s PEG Ratio Range Over the Past 10 Years
Min: 0.58  Med: 1.72 Max: 4.36
Current: 4.06
0.58
4.36
Shiller PE Ratio 37.22
WAT's Shiller PE Ratio is ranked higher than
65% of the 51 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.91 vs. WAT: 37.22 )
Ranked among companies with meaningful Shiller PE Ratio only.
WAT' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.64  Med: 30.02 Max: 51.34
Current: 37.22
16.64
51.34
Current Ratio 6.04
WAT's Current Ratio is ranked higher than
83% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. WAT: 6.04 )
Ranked among companies with meaningful Current Ratio only.
WAT' s Current Ratio Range Over the Past 10 Years
Min: 1.19  Med: 1.9 Max: 6.99
Current: 6.04
1.19
6.99
Quick Ratio 5.60
WAT's Quick Ratio is ranked higher than
85% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. WAT: 5.60 )
Ranked among companies with meaningful Quick Ratio only.
WAT' s Quick Ratio Range Over the Past 10 Years
Min: 0.74  Med: 1.52 Max: 6.48
Current: 5.6
0.74
6.48
Days Inventory 113.79
WAT's Days Inventory is ranked higher than
60% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.23 vs. WAT: 113.79 )
Ranked among companies with meaningful Days Inventory only.
WAT' s Days Inventory Range Over the Past 10 Years
Min: 96.3  Med: 107.8 Max: 113.79
Current: 113.79
96.3
113.79
Days Sales Outstanding 76.37
WAT's Days Sales Outstanding is ranked lower than
72% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.37 vs. WAT: 76.37 )
Ranked among companies with meaningful Days Sales Outstanding only.
WAT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.61  Med: 79.57 Max: 83.7
Current: 76.37
67.61
83.7
Days Payable 28.48
WAT's Days Payable is ranked lower than
80% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.31 vs. WAT: 28.48 )
Ranked among companies with meaningful Days Payable only.
WAT' s Days Payable Range Over the Past 10 Years
Min: 26.08  Med: 28.41 Max: 35.98
Current: 28.48
26.08
35.98

Buy Back

vs
industry
vs
history
5-Year Yield-on-Cost % 0.10
WAT's 5-Year Yield-on-Cost % is ranked lower than
98% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. WAT: 0.10 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
WAT' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.1
3-Year Average Share Buyback Ratio 1.90
WAT's 3-Year Average Share Buyback Ratio is ranked higher than
92% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -4.10 vs. WAT: 1.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
WAT' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.1  Med: 2.4 Max: 6.3
Current: 1.9
-3.1
6.3

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 23.23
WAT's Price-to-Net-Cash is ranked lower than
62% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.35 vs. WAT: 23.23 )
Ranked among companies with meaningful Price-to-Net-Cash only.
WAT' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 22.7  Med: 59.35 Max: 401.52
Current: 23.23
22.7
401.52
Price-to-Net-Current-Asset-Value 10.24
WAT's Price-to-Net-Current-Asset-Value is ranked lower than
60% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.73 vs. WAT: 10.24 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
WAT' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 8.43  Med: 15.91 Max: 310.33
Current: 10.24
8.43
310.33
Price-to-Tangible-Book 7.75
WAT's Price-to-Tangible-Book is ranked lower than
67% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.82 vs. WAT: 7.75 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
WAT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.17  Med: 11.64 Max: 1545.29
Current: 7.75
6.17
1545.29
Price-to-Intrinsic-Value-Projected-FCF 2.19
WAT's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
54% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.18 vs. WAT: 2.19 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
WAT' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.87  Med: 1.65 Max: 10.23
Current: 2.19
0.87
10.23
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.85
WAT's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
57% of the 21 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. WAT: 1.85 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
WAT' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.5  Med: 1.14 Max: 2.82
Current: 1.85
0.5
2.82
Price-to-Median-PS-Value 1.50
WAT's Price-to-Median-PS-Value is ranked lower than
70% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. WAT: 1.50 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
WAT' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.28  Med: 0.96 Max: 3.4
Current: 1.5
0.28
3.4
Price-to-Peter-Lynch-Fair-Value 3.51
WAT's Price-to-Peter-Lynch-Fair-Value is ranked lower than
64% of the 44 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.18 vs. WAT: 3.51 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
WAT' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.66  Med: 1.7 Max: 5.81
Current: 3.51
0.66
5.81
Price-to-Graham-Number 3.13
WAT's Price-to-Graham-Number is ranked lower than
53% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. WAT: 3.13 )
Ranked among companies with meaningful Price-to-Graham-Number only.
WAT' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 2.34  Med: 3.31 Max: 49.57
Current: 3.13
2.34
49.57
Earnings Yield (Greenblatt) % 4.78
WAT's Earnings Yield (Greenblatt) % is ranked higher than
76% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. WAT: 4.78 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
WAT' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.2  Med: 6.1 Max: 12.4
Current: 4.78
4.2
12.4
Forward Rate of Return (Yacktman) % 10.90
WAT's Forward Rate of Return (Yacktman) % is ranked higher than
55% of the 97 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.48 vs. WAT: 10.90 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
WAT' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 9.1  Med: 15 Max: 26.6
Current: 10.9
9.1
26.6

More Statistics

Revenue (TTM) (Mil) $2,211.84
EPS (TTM) $ 6.62
Beta1.21
Short Percentage of Float3.71%
52-Week Range $133.35 - 190.39
Shares Outstanding (Mil)79.82

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 2,289 2,399 2,530
EPS ($) 7.30 7.88 8.63
EPS without NRI ($) 7.30 7.88 8.63
EPS Growth Rate
(Future 3Y To 5Y Estimate)
7.67%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}